Vesper Bio ApS: Financial statements 2019
CVR: 32879861
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -2,769,107 compared with DKK -3,992,474 the year before. Equity in the 2019 report amounted to DKK 1,123,950. The solvency ratio was 63.3%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -2,769,107
- Equity
- DKK 1,123,950
- Total Assets
- DKK 1,775,683
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -2.8 mio. | 1.1 mio. | 1 |
| 2018 | - | - | -4 mio. | 3.9 mio. | 1 |
| 2017 | - | - | -2.7 mio. | 7.9 mio. | 0 |
| 2016 | - | - | -4 mio. | 3.1 mio. | - |
| 2015 | - | - | -6.1 mio. | 7.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Vesper Bio ApS has published its annual report for 2018. The net result was DKK -3,992,474.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity in the 2025 report amounted to DKK -227,433,239.